News
12hon MSN
Metagenomi Inc. (NASDAQ:MGX) is one of the best young stocks to buy and hold for 5 years. In mid-May, Metagenomi announced ...
Advancements in gene editing, strategic partnerships, and supportive regulations fuel global CRISPR adoption across healthcare and agriculture. DELAWARE, DE, UNITED STATES, July 14, 2025 /EINPresswire ...
CRISPR Therapeutics is revolutionizing medicine with gene editing. Learn more about CRSP's breakthroughs, stock rally, and ...
Rare genetic diseases are challenging for patients and their families—made all the more overwhelming because symptoms tend to ...
Learn more about the research of Mayo Clinic's Gene Editing and Cellular Engineering Laboratory led by David (Chun-Wei) D.
4don MSN
The Canadian government is currently considering approving the entry of gene-edited pigs into the food system.
The global CRISPR gene editing market size is calculated at USD 4.77 billion in 2025 and is expected to reach around USD ...
A glucose-sensitive nanovaccine delivers CRISPR to tumors, silences immune-suppressing genes, and activates a targeted immune response against cancer.
Scientists have created a near-copy of the long-extinct dire wolf. Using advanced CRISPR gene editing tech, it now looks ...
Broken String Biosciences, a leader in advancing gene editing safety, and BioLizard, an expert in scientific data analytics ...
6d
News-Medical.Net on MSNNew funding brings personalized CRISPR cures closer to children with rare diseasesPersonalized CRISPR cures for children born with rare genetic diseases are now a step closer to being more widely available.
CRISPR construct to genetically ablate the GABA transporter GAT3 in the mouse visual cortex, with effects on population-level neuronal activity. This work is important, as it sheds light on how GAT3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results